Stay updated on Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.

Latest updates to the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPublications section text updated to say publications are automatically filled from PubMed and may not be about the study, with a revision tag showing v3.3.2. The previous wording implying PubMed sources was replaced.SummaryDifference0.0%

- Check28 days agoChange DetectedThe page removed a government funding status notice about potential delays in updates and operating status, which previously advised users about where to check for updates (e.g., opm.gov). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedNo significant additions or deletions to core study information (such as study status, eligibility criteria, enrollment, primary outcomes, or location lists) are visible between the two screenshots, indicating the page content remained essentially the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check70 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference2%

- Check78 days agoChange DetectedThe page update adds v3.1.0 and removes v3.0.2, signaling a new version without altering substantive content.SummaryDifference0.0%

- Check92 days agoChange DetectedUpdate: Revision changed from v3.0.1 to v3.0.2; 'Back to Top' was removed.SummaryDifference0.1%

Stay in the know with updates to Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.